2018 Nobel Prize in medicine awarded to cancer immunotherapy: Immune checkpoint blockade - A personal account
- PMID: 30591930
- PMCID: PMC6303476
- DOI: 10.1016/j.gendis.2018.10.003
2018 Nobel Prize in medicine awarded to cancer immunotherapy: Immune checkpoint blockade - A personal account
Figures
References
-
- The Nobel Prize in Physiology or Medicine. 2018. https://www.nobelprize.org/prizes/medicine/2018/press-release/
-
- Leach D.R., Krummel M.F., Allison J.P. Enhancement of antitumor immunity by CTLA-4 blockade. Science. 1996;271:1734–1736. - PubMed
-
- FDA approves YERVOY™ (ipilimumab) for the treatment of patients with newly diagnosed or previously-treated unresectable or metastatic melanoma. https://news.bms.com/press-release/rd-news/fda-approves-yervoy-ipilimuma....
-
- Nishimura H., Nose M., Hiai H., Minato N., Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity. 1999;11:141–151. - PubMed
LinkOut - more resources
Full Text Sources
